Despite a challenging macroeconomic context affecting transactions during the start of 2023, the US healthcare sector is preparing for an upcoming wave of M&A activity going forward, according to RBC Capital Markets. Compressed valuations, heightened boardroom CEO confidence across various sub-sectors, and the need to accelerate top-line growth and scale are all indicative of a wave of deal activity.
Tough financing markets and access to capital are impacting the decisions of smaller-mid cap companies – who are examining strategic alternatives including acquisition deals to boost value, RBC notes in a podcast. Read more.
